» Articles » PMID: 36341376

Alveolar Macrophages and Airway Hyperresponsiveness Associated with Respiratory Syncytial Virus Infection

Overview
Journal Front Immunol
Date 2022 Nov 7
PMID 36341376
Authors
Affiliations
Soon will be listed here.
Abstract

Respiratory syncytial virus (RSV) is a ubiquitous pathogen of viral bronchiolitis and pneumonia in children younger than 2 years of age, which is closely associated with recurrent wheezing and airway hyperresponsiveness (AHR). Alveolar macrophages (AMs) located on the surface of the alveoli cavity are the important innate immune barrier in the respiratory tract. AMs are recognized as recruited airspace macrophages (RecAMs) and resident airspace macrophages (RAMs) based on their origins and roaming traits. AMs are polarized in the case of RSV infection, forming two macrophage phenotypes termed as M1-like and M2-like macrophages. Both M1 macrophages and M2 macrophages are involved in the modulation of inflammatory responses, among which M1 macrophages are capable of pro-inflammatory responses and M2 macrophages are capable of anti-proinflammatory responses and repair damaged tissues in the acute and convalescent phases of RSV infection. Polarized AMs affect disease progression through the alteration of immune cell surface phenotypes as well as participate in the regulation of T lymphocyte differentiation and the type of inflammatory response, which are closely associated with long-term AHR. In recent years, some progress have been made in the regulatory mechanism of AM polarization caused by RSV infection, which participates in acute respiratory inflammatory response and mediating AHR in infants. Here we summarized the role of RSV-infection-mediated AM polarization associated with AHR in infants.

Citing Articles

Short-Chain Fatty Acids: Promising Therapeutic Targets for Respiratory Syncytial Virus Infection.

Liang M, Dong Q, Wu W, Fan J Clin Rev Allergy Immunol. 2025; 68(1):8.

PMID: 39873814 DOI: 10.1007/s12016-024-09018-x.


Analysis of Beyfortus (Nirsevimab) Immunization Campaign: Effectiveness, Biases, and ADE Risks in RSV Prevention.

Banoun H Curr Issues Mol Biol. 2024; 46(9):10369-10395.

PMID: 39329969 PMC: 11431526. DOI: 10.3390/cimb46090617.


Transcriptome profiling of macrophages persistently infected with human respiratory syncytial virus and effect of recombinant calreticulin on immune-related genes.

Rivera-Toledo E, Fernandez-Rojas M, Santiago-Olivares C, Cruz-Rivera M, Hernandez-Bautista V, Avila-Horta F Front Microbiol. 2024; 15:1402589.

PMID: 39296294 PMC: 11408361. DOI: 10.3389/fmicb.2024.1402589.


The correlation between the level of cellular classification in bronchoalveolar lavage fluid of children with severe Mycoplasma pneumoniae and clinical characteristics.

Ma K, Liu X, Wu X, Wang T, Li K, Wang D Eur J Pediatr. 2024; 183(10):4351-4362.

PMID: 39093423 DOI: 10.1007/s00431-024-05700-6.


Cholinergic Polarization of Human Macrophages.

Roa-Vidal N, Rodriguez-Aponte A, Lasalde-Dominicci J, Capo-Velez C, Delgado-Velez M Int J Mol Sci. 2023; 24(21).

PMID: 37958716 PMC: 10650439. DOI: 10.3390/ijms242115732.


References
1.
Qin L, Qiu K, Hu C, Wu G, Wang L, Tan Y . Bronchial Epithelial Cells Promote the Differentiation of Th2 Lymphocytes in Airway Microenvironment through Jagged/Notch-1 Signaling after RSV Infection. Int Arch Allergy Immunol. 2019; 179(1):43-52. DOI: 10.1159/000495581. View

2.
Shiomi A, Usui T . Pivotal roles of GM-CSF in autoimmunity and inflammation. Mediators Inflamm. 2015; 2015:568543. PMC: 4370199. DOI: 10.1155/2015/568543. View

3.
Kawano H, Kayama H, Nakama T, Hashimoto T, Umemoto E, Takeda K . IL-10-producing lung interstitial macrophages prevent neutrophilic asthma. Int Immunol. 2016; 28(10):489-501. DOI: 10.1093/intimm/dxw012. View

4.
Rossaint J, Thomas K, Mersmann S, Skupski J, Margraf A, Tekath T . Platelets orchestrate the resolution of pulmonary inflammation in mice by T reg cell repositioning and macrophage education. J Exp Med. 2021; 218(7). PMC: 8142284. DOI: 10.1084/jem.20201353. View

5.
Makris S, Bajorek M, Culley F, Goritzka M, Johansson C . Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons. J Innate Immun. 2016; 8(5):452-63. PMC: 5322584. DOI: 10.1159/000446824. View